| Literature DB >> 24842666 |
Helaine Graziele Santos Vieira1, Priscila Grynberg2, Mainá Bitar1, Simone da Fonseca Pires3, Heron Oliveira Hilário1, Andrea Mara Macedo1, Carlos Renato Machado1, Hélida Monteiro de Andrade3, Glória Regina Franco1.
Abstract
Trypanosoma cruzi, the causative agent of Chagas disease, is extremely resistant to ionizing radiation, enduring up to 1.5 kGy of gamma rays. Ionizing radiation can damage the DNA molecule both directly, resulting in double-strand breaks, and indirectly, as a consequence of reactive oxygen species production. After a dose of 500 Gy of gamma rays, the parasite genome is fragmented, but the chromosomal bands are restored within 48 hours. Under such conditions, cell growth arrests for up to 120 hours and the parasites resume normal growth after this period. To better understand the parasite response to ionizing radiation, we analyzed the proteome of irradiated (4, 24, and 96 hours after irradiation) and non-irradiated T. cruzi using two-dimensional differential gel electrophoresis followed by mass spectrometry for protein identification. A total of 543 spots were found to be differentially expressed, from which 215 were identified. These identified protein spots represent different isoforms of only 53 proteins. We observed a tendency for overexpression of proteins with molecular weights below predicted, indicating that these may be processed, yielding shorter polypeptides. The presence of shorter protein isoforms after irradiation suggests the occurrence of post-translational modifications and/or processing in response to gamma radiation stress. Our results also indicate that active translation is essential for the recovery of parasites from ionizing radiation damage. This study therefore reveals the peculiar response of T. cruzi to ionizing radiation, raising questions about how this organism can change its protein expression to survive such a harmful stress.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24842666 PMCID: PMC4026238 DOI: 10.1371/journal.pone.0097526
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1The effect of irradiation and translation inhibition on T. cruzi epimastigotes growth.
Irradiated (500 Gy) or NI parasites were treated with cycloheximide 50 µg/mL (A) or puromycin 25 µg/mL (B), both added 4 hours after irradiation. Each point represents the mean ± standard deviation of three different experiments.
Experimental design.
| Gel | NI | 4 h | 24 h | 96 h | Pool |
| 1 | Cy3 | Cy5 | Cy2 | ||
| 2 | Cy3 | Cy5 | Cy2 | ||
| 3 | Cy3 | Cy5 | Cy2 | ||
| 4 | Cy5 | Cy3 | Cy2 | ||
| 5 | Cy3 | Cy5 | Cy2 | ||
| 6 | Cy3 | Cy5 | Cy2 |
Each two-dimensional gel was loaded with 50 µg of total protein extract per sample, labeled either with Cy3 or Cy5. The internal control (a pool containing 50 µg of all time point proteins: NI, 4, 24, and 96 hours after irradiation) was labeled with Cy2.
Figure 22D-DIGE analysis of total protein extracts of irradiated and NI epimastigote cells.
Gel images 1–6 (see the experimental design in Table 1) showing – in triplicate – parasite proteins from each time point, labeled either with Cy3 (green) or Cy5 (red). Proteins were separated in the first dimension along a pH gradient (pH 4–7, 18 cm Immobiline DryStrip (GE Healthcare, USA), and in the second dimension in a 12% polyacrylamide gel. The molecular weight marker (MW) is indicated in kDa.
Protein data for the 53 proteins identified in this study.
| Observed/Expected | Fold-change | Mascot MS/MS ion search | |||||||||
| Description | TriTrypDB ID (TcCLB.) | Ref. Spot | pI | MW | 4 hs | 24 hs | 96 hs | Anova | Peptides matched | Sequence covarage | Mascot score |
| 14-3-3 protein; putative | 511167.90 | 153 | 5.00/4.78 | 24.3/29.1 | −1.35 | 1.08 | −1.16 | 5.61E–5 | 2 | 12% | 73 |
| 40S ribosomal protein S12, putative | 508551.20 | 195 | 4.82/4.78 | 10.9/15.9 | 1.45 | 3.52 | 2.92 | 1.32E–5 | 2 | 24% | 110 |
| Actin, putative | 510571.39 or 510127.79 or 510571.30 | 66 | 5.75/5.46 | 45.9/41.2 | −1.64 | −14.92 | −12.65 | 8.20E–9 | 3 | 10% | 136 |
| Alpha tubulin, putative | 411235.9 | 69 | 6.07/4.7 | 44.7/49.8 | −1.01 | −12.65 | −10.53 | 2.00E–7 | 5 | 16% | 248 |
| 99 | 5/4.7 | 55.6/49.8 | −1.94 | −31.15 | −48.82 | 2.97E–8 | 11 | 42% | 89 | ||
| 100 | 5.06/4.7 | 55.2/49.8 | −2.11 | −47.2 | −45.08 | 1.34E–9 | 5 | 15% | 275 | ||
| 136 | 5.29/4.7 | 29.9/49.8 | 1.54 | −2.02 | −1.68 | 8.44E–9 | 4 | 14% | 247 | ||
| 138 | 5.47/4.7 | 30.4/49.8 | 1.09 | −2.34 | −2.21 | 8.55E–7 | 3 | 9% | 155 | ||
| 139 | 5.45/4.7 | 28.9/49.8 | 1.36 | −1.95 | −1.63 | 6.52E–8 | 4 | 13% | 237 | ||
| Aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17, putative | 508799.240 | 35 | 6.22/6.44 | 58.9/55.9 | −1.55 | −−1.53 | −1.73 | 5.40E–5 | 1 | 2% | 52 |
| ATPase beta subunit | 509233.180 | 26 | 5.15/5.07 | 58.6/55.7 | −2.42 | −21.04 | −18.44 | 7.26E–7 | 5 | 18% | 253 |
| Beta tubulin, putative | 506563.40 | 107 | 5.58/4.43 | 45.0/49.7 | −1.36 | −4.9 | −5.17 | 1.02E–7 | 3 | 7% | 156 |
| 129 | 5.30/4.43 | 33.3/49.7 | −1.01 | −4.35 | −3.99 | 1.53E–7 | 5 | 13% | 242 | ||
| 130 | 5.15/4.43 | 33.8/49.7 | −1.31 | −10.73 | −9.26 | 4.56E–8 | 6 | 17% | 438 | ||
| 171 | 4.71/4.43 | 28.6/49.7 | 1.8 | 1.69 | 2.07 | 1.49E–8 | 7 | 22% | 73 | ||
| 173 | 4.65/4.43 | 25.5/49.7 | 2.53 | 6.33 | 5.29 | 8.44E–9 | 4 | 11% | 237 | ||
| 174 | 4.58/4.43 | 25.5/49.7 | 1.16 | 2.59 | 2.43 | 1.17E–6 | 4 | 11% | 290 | ||
| 176 | 4.47/4.43 | 25.0/49.7 | 1.7 | 3.58 | 3.52 | 2.60E–7 | 3 | 9% | 216 | ||
| 183 | 4.34/4.43 | 19.4/49.7 | 1.15 | 2.38 | 1.93 | 1.27E–5 | 2 | 6% | 101 | ||
| 184 | 4.25/4.43 | 19.4/49.7 | 1.56 | 5.97 | 5.14 | 3.49E–8 | 2 | 6% | 116 | ||
| 185 | 4.25/4.43 | 21.2/49.7 | 1.67 | 4.39 | 4.22 | 3.61E–6 | 2 | 6% | 133 | ||
| Calreticulin, putative | 510685.10 | 81 | 6.37/4.49 | 42.2/46.2 | −1.07 | 1 | 1.52 | 1.81E–5 | 2 | 6% | 89 |
| Chaperonin containing t-complex protein, putative | 511725.250 | 12 | 5.02/4.80 | 69.7/59.2 | −1.95 | −12.81 | −16.4 | 4.12E–7 | 3 | 9% | 113 |
| Chaperonin HSP60; mitochondrial precursor; GroEL protein; heat shock protein 60 (HSP60) | 507641.290 or 507641.300 or 510187.551 | 17 | 5.44/5.14 | 66.2/59.2 | −4.9 | −19.19 | −19.86 | 1.27E–8 | 9 | 24% | 470 |
| 18 | 5.55/5.14 | 66.0/59.2 | −4.07 | −9.24 | −10.18 | 1.75E–8 | 3 | 20% | 111 | ||
| 20 | 5.65/5.14 | 65.8/59.2 | −3.99 | −8.83 | −9.9 | 1.25E–7 | 7 | 18% | 354 | ||
| 23 | 5.22/5.14 | 62.3/59.2 | −2.03 | −8.02 | −9.51 | 6.42E–8 | 7 | 18% | 191 | ||
| 24 | 5.13/5.14 | 62.2/59.2 | −1.72 | −11.52 | −13.96 | 9.42E–8 | 11 | 31% | 533 | ||
| 25 | 5.21/5.14 | 61.5/59.2 | −1.78 | −16.99 | −15.1 | 1.61E–7 | 6 | 16% | 205 | ||
| 28 | 5.29/5.14 | 62.0/59.2 | −2.16 | −9.12 | −9.25 | 3.25E–8 | 5 | 14% | 195 | ||
| 88 | 4.68/5.14 | 51.2/59.2 | −1.06 | −3.44 | −2.79 | 9.76E–7 | 3 | 18% | 112 | ||
| 89 | 4.83/5.14 | 51.8/59.2 | −1.28 | −7.85 | −7.58 | 3.21E–7 | 3 | 18% | 150 | ||
| 106 | 5.5/5.14 | 43.1/59.2 | 1.23 | −5.57 | −4.86 | 2.11E–7 | 6 | 15% | 177 | ||
| 131 | 5.03/5.14 | 34.0/59.2 | −1.76 | −9.8 | −7.3 | 3.45E–8 | 1 | 5% | 76 | ||
| 162 | 5.66/5.14 | 20.3/59.2 | 1.97 | 1.81 | 1.97 | 4.31E–7 | 2 | 10% | 62 | ||
| Chaperonin; Tcomplex-protein 1; theta subunit; putative | 506247.50 | 16 | 5.42/5.12 | 68.9/58.3 | −2.42 | −4.81 | −5.44 | 6.21E–8 | 3 | 7% | 138 |
| Cystathionine beta-synthase, cysteine synthase, serine sulfhydrylase (CBS) | 508177.120 or 506905.50 or | 78 | 6.83/7.14 | 45.0/47.0 | −1.1 | −2.96 | −2.21 | 1.61E–7 | 4 | 13% | 206 |
| 508175.360 or 511691.10 | 80 | 6.37/7.14 | 45.3/47.0 | −1.98 | −10.23 | −12.17 | 1.75E–8 | 2 | 7% | 88 | |
| Cytochrome c oxidase subunit IV; putative | 506529.360 or 510889.50 | 124 | 5.51/5.96 | 36.0/38.9 | −1.01 | −1.92 | −1.58 | 5.98E–7 | 2 | 7% | 105 |
| Cytochrome c oxidase subunit V, putative | 510565.30 or 508503.20 | 200 | 5.5/6.4 | 14.8/22.2 | 1.99 | 6.2 | 5.12 | 1.53E–7 | 2 | 14% | 69 |
| D-isomer specific2-hydroxyacid dehydrogenase-protein | 510099.120 | 119 | 6.72/6.41 | 35.2/38.5 | −1.46 | −6.4 | −5.31 | 6.69E–7 | 12 | 36% | 103 |
| 197 | 5.26/6.41 | 11.2/38.5 | 1.13 | −4.38 | −3.75 | 9.76E–9 | 6 | 20% | 321 | ||
| Dihydrolipoamide acetyltransferase precursor | 509717.20 and 510105.170 | 0 | 5.75/6.39 | 62.2/49.6 | −1.32 | −7.65 | −5.03 | 1.75E–8 | 1 | 3% | 61 |
| 33 | 5.91/6.68 | 62.1/49.6 | −1.49 | −7.45 | −6.79 | 4.65E–9 | 4 | 14% | 167 | ||
| Dihydrolipoyl dehydrogenase; putative (GCVL-2) | 507089.270 or 511025.110 | 73 | 6.69/7.4 | 52.5/54.9 | 1.01 | −2.41 | −2.34 | 2.36E–7 | 3 | 7% | 98 |
| Dipeptidyl-peptidase | 508601.141 or 509205.120 | 29 | 5.40/5.60 | 62.4/74.4 | −2.19 | −5.73 | −4.96 | 5.14E–8 | 2 | 3% | 58 |
| 30 | 5.48/5.63 | 62.3/74.4 | −1.9 | −7.12 | −8.88 | 1.75E–8 | 3 | 6% | 139 | ||
| Drug resistance protein | 444777.10 | 123 | 5.54/4.05 | 37.2/50.3 | −1.18 | 1.68 | 2.34 | 5.72E–6 | 1 | 5% | 26 |
| Elongation factor 2, putative | 510963.90 | 36 | 6.36/5.86 | 55.8/94.2 | −1.82 | −6.16 | −5.58 | 5.78E–8 | 4 | 6% | 197 |
| 49 | 5.95/5.86 | 54.6/94.2 | −1.99 | −7.15 | −6.91 | 2.60E–7 | 3 | 4% | 130 | ||
| 50 | 5.99/5.86 | 54.6/94.2 | −1.93 | −11.21 | −11.53 | 3.72E–9 | 4 | 6% | 146 | ||
| 65 | 5.78/5.86 | 50.2/94.2 | −1.4 | −12.96 | −9.24 | 3.48E–7 | 6 | 8% | 325 | ||
| 125 | 5.34/5.86 | 36.0/94.2 | −1.2 | −7.53 | −7.72 | 1.34E–9 | 5 | 9% | 293 | ||
| 112 | 5.96/5.86 | 38.0/94.2 | 1.11 | −2.38 | −1.3 | 6.35E–4 | 4 | 6% | 151 | ||
| 137 | 5.38/5.86 | 30.7/94.2 | 1.83 | 1.32 | 1.98 | 2.44E–7 | 3 | 2% | 92 | ||
| Enolase | 504105.140 | 72 | 6.54/6.2 | 50.6/46.4 | −2.63 | −5.28 | −6.37 | 6.94E–8 | 2 | 7% | 73 |
| Eukaryotic translation initiation factor 6 (elF-6); putative | 506679.70 | 168 | 5.04/6.09 | 20.7/33.2 | 1.55 | 1.31 | 1.27 | 3.90E–5 | 2 | 9% | 127 |
| Glucose-regulated protein 78, putative | 506585.40 | 2 | 5.19/4.82 | 76.9/71.3 | −2.45 | −23.64 | −16.54 | 1.02E–7 | 4 | 12% | 198 |
| 13 | 4.98/4.82 | 67.1/71.3 | 1.21 | −2.77 | −2.68 | 1.91E–6 | 2 | 4% | 88 | ||
| 95 | 4.72/4.82 | 45.7/71.3 | −1.08 | −4.09 | −3.33 | 7.81E–7 | 2 | 3% | 74 | ||
| 96 | 4.58/4.82 | 45.4/71.3 | 1.52 | 1.68 | 1.52 | 4.25E–5 | 4 | 9% | 297 | ||
| Glutamamyl caboxypeptidase; putative | 507689.40 or 507657.20 or 507657.10 | 70 | 6.18/6.51 | 47.6/43.4 | −1.22 | −2.15 | −2.41 | 1.66E–6 | 2 | 6% | 92 |
| 76 | 6.53/6.51 | 47.0/43.4 | −1.28 | −2.09 | −2.19 | 5.13E–7 | 2 | 6% | 110 | ||
| 77 | 6.59/6.51 | 45.5/43.4 | −1.23 | −2.99 | −2.31 | 1.36E–7 | 3 | 9% | 129 | ||
| Glutamate dehydrogenase | 508111.30 | 212 | 6.72/8.05 | 15.9/45.0 | 1.62 | 1.64 | 2 | 6.63E–6 | 2 | 7% | 77 |
| 213 | 6.79/8.05 | 15.9/45/0 | 1.88 | 2.39 | 2.64 | 4.83E–8 | 2 | 7% | 110 | ||
| 214 | 6.78/8.05 | 15.1/45.0 | 1.86 | 3.66 | 4.03 | 6.54E–9 | 4 | 13% | 173 | ||
| Glycerate kinase, putative | 508741.170 | 159 | 6.49/8.21 | 20.7/56.1 | 1.37 | −1.87 | −2.19 | 1.43E–6 | 1 | 3% | 37 |
| Heat-shock protein 70kDa, putative | 509543.50 and 511257.10 | 1 | 5.14/4.55 | 76.1/70.0 | −2.15 | −9.69 | −10.51 | 3.28E–8 | 2 | 11% | 70 |
| 90 | 4.90/4.55 | 51.8/70.0 | −1.16 | −4.64 | −5.4 | 2.91E–7 | 2 | 11% | 79 | ||
| 91 | 4.98/4.60 | 52.6/70.0 | −1.12 | −4.52 | −3.7 | 2.44E–7 | 4 | 18% | 205 | ||
| Heat-shock protein 70kDa, putative | 506135.9 | 155 | 5.63/6.56 | 23.4/30.2 | 1.7 | 2.79 | 2.2 | 5.79E–5 | 2 | 10% | 88 |
| Heat-shock protein 70kDa, putative | 511211.160 | 7 | 5.55/5.85 | 72.7/70.9 | −1.34 | −4.53 | −3.34 | 1.15E–7 | 4 | 15% | 191 |
| 92 | 5.00/5.85 | 47.8/70.9 | −1.11 | −5.67 | −5.23 | 8.47E–8 | 2 | 11% | 67 | ||
| 101 | 5.13/5.85 | 44.1/70.9 | 1.3 | −3.49 | −3.28 | 4.17E–9 | 2 | 4% | 67 | ||
| 105 | 5.50/5.85 | 44.9/70.9 | −1.49 | −4.58 | −3.7 | 1.75E–7 | 2 | 4% | 78 | ||
| 156 | 5.86/5.85 | 23.1/70.9 | 1.87 | 2.21 | 1.66 | 2.44E–7 | 4 | 19% | 181 | ||
| 160 | 6.72/5.85 | 23.0/70.9 | 1.08 | −2.66 | −2.99 | 2.96E–8 | 13 | 48% | 107 | ||
| 164 | 5.32/5.85 | 22.1/70.9 | 1.65 | 1.87 | 1.5 | 8.47E7 | 4 | 14% | 214 | ||
| 175 | 4.56/5.85 | 24.1/70.9 | 1.23 | 1.34 | 1.38 | 8.68E–5 | 1 | 2% | 66 | ||
| 177 | 4.65/5.85 | 20.8/70.9 | 2.01 | 5.22 | 4.11 | 5.33E−8 | 1 | 2% | 72 | ||
| Heat shock 70 kDa protein, mitochondrial precursor, putative | 507029.30 | 8 | 5.65/5.71 | 72.4/71.0 | −1.39 | −4.87 | −3.73 | 9.36E–9 | 2 | 4% | 81 |
| 9 | 5.77/5.71 | 72.7/71.0 | −1.42 | −5.3 | −4 | 9.88E–9 | 6 | 14% | 293 | ||
| 10 | 5.90/5.71 | 73.1/71.0 | −1.32 | −3.83 | −3.08 | 7.83E–8 | 3 | 7% | 85 | ||
| 11 | 5.87/5.71 | 69.7/71.0 | −1.05 | −1.87 | −1.94 | 1.55E–5 | 4 | 10% | 152 | ||
| 19 | 5.60/5.71 | 67.4/71.0 | 1.18 | −1.4 | −1.53 | 1.17E–6 | 5 | 12% | 285 | ||
| 21 | 5.73/5.71 | 67.7/71.0 | 1.26 | −1.42 | −1.58 | 1.70E–7 | 4 | 10% | 109 | ||
| Heat-shock protein 85kDa, putative | 509643.130 or 507713.30 or 509105.140 | 93 | 4.89/4.79 | 47.6/80.7 | −1.44 | −5.4 | −4.32 | 7.81E–7 | 2 | 3% | 87 |
| 97 | 4.90/4.79 | 43.2/80.7 | 1.43 | −1.5 | −1.15 | 3.25E–7 | 3 | 5% | 114 | ||
| 98 | 4.95/4.79 | 43.0/80.7 | 1.02 | −3.01 | −3.37 | 1.49E–8 | 2 | 3% | 145 | ||
| 104 | 5.30/4.79 | 41.5/80.7 | −1.63 | −16.15 | −18.55 | 2.26E–8 | 3 | 5% | 143 | ||
| 126 | 5.40/4.79 | 33.5/80.7 | 1.2 | −3.77 | −3.74 | 4.34E–8 | 2 | 3% | 89 | ||
| 134 | 4.62/4.79 | 40.6/80.7 | 1.39 | 2.58 | 2.18 | 7.35E–6 | 4 | 6% | 258 | ||
| 148 | 4.95/4.79 | 28.8/80.7 | 1.76 | 2.78 | 2.47 | 3.49E–8 | 1 | 1% | 100 | ||
| 149 | 4.86/4.79 | 28.9/80.7 | 1.67 | 3.55 | 3.23 | 6.89E–8 | 1 | 1% | 62 | ||
| Hypothetical protein, conserved | 505989.110 | 182 | 4.46/4.50 | 18.4/22.2 | −1.25 | 3.47 | 3.51 | 1.92E–5 | 2 | 11% | 62 |
| Hypothetical protein, conserved | 506605.120 or 511239.110 | 202 | 5.72/4.99 | 15.1/28.6 | 2.75 | 7.08 | 7.83 | 1.34E–9 | 4 | 22% | 174 |
| 203 | 5.67/4.99 | 14.2/28.6 | 1.87 | 3.96 | 3.33 | 3.66E–6 | 9 | 41% | 92 | ||
| 204 | 5.86/4.99 | 14.1/28.6 | 1.48 | 2.12 | 2.78 | 1.88E–7 | 6 | 31% | 326 | ||
| Hypothetical protein | 508817.20 or 503801.70 | 154 | 5.38/8.58 | 23.5/66.7 | 1.78 | 4.80 | 4.29 | 3.96E–8 | 1 | 1% | 17 |
| Nucleoside phosphorylase, putative | 508989.9 and 509569.100 | 121 | 6.90/6.42 | 34.2/37.0 | −1.18 | −5.59 | −4.38 | 2.96E–8 | 3 | 16% | 190 |
| 118 | 6.38/6.42 | 35.6/37.0 | −1.12 | −3.17 | −2.56 | 1.17E–8 | 1 | 4% | 23 | ||
| Oligopeptidase B, putative | 503995.50 | 47 | 5.86/6.1 | 55.2/80.8 | −1.71 | −5.94 | −7.55 | 9.76E–9 | 2 | 3% | 68 |
| 63 | 5.86/6.1 | 52.0/80.9 | −1.12 | −2.26 | −2.47 | 8.01E–7 | 2 | 3% | 69 | ||
| Paraflagellar rod protein 3 | 509617.20 | 60 | 6.09/5.96 | 56.1/68.6 | 1.21 | −3.51 | −4.33 | 6.89E–8 | 1 | 2% | 24 |
| Peptidase M20/M25/M40 | 510257.80 | 39 | 5.57/5.19 | 55.4/51.2 | −1.74 | −5.55 | −7.07 | 8.47E–7 | 2 | 6% | 66 |
| 40 | 5.50/5.19 | 54.4/51.2 | −1.64 | −5.35 | −9.41 | 2.26E–8 | 1 | 3% | 31 | ||
| Peroxiredoxin; tryparedoxin peroxidase | 509499.14 | 189 | 5.16/7.92 | 18.1/25.5 | 1.11 | 1.42 | 1.73 | 7.81E–7 | 3 | 15% | 174 |
| Phosphoglycerate kinase, putative or 3-phosphoglycerate kinase, glycosomal (PGKA) | 511419.40 or 505999.90 or 511419.50 or 505999.100 | 74 | 6.76/7.4 | 51.9/54.90 | −2.99 | −5.56 | −5.35 | 2.46E–7 | 1 | 3% | 78 |
| Prostaglandin F2 alpha synthase (TcPGFS) | 508461.80 | 14 | 5.11/6.43 | 68.1/42.2 | −1.19 | −6.45 | −7.01 | 1.59E–6 | 4 | 14% | 169 |
| 111 | 5.91/6.43 | 40.0/42.2 | −1.31 | −11.76 | −7.75 | 1.74E–8 | 5 | 17% | 284 | ||
| 113 | 6.10/6.43 | 40.0/42.2 | −1.11 | −10.19 | −6.05 | 1.75E–8 | 8 | 38% | 116 | ||
| 114 | 6.09/6.43 | 38.7/42.2 | 1.12 | −6.24 | −5.06 | 3.12E–7 | 4 | 13% | 188 | ||
| 144 | 6.15/6.43 | 26.7/42.2 | 1.49 | −1.65 | −1.39 | 5.49E–8 | 4 | 13% | 217 | ||
| 161 | 5.52/6.43 | 22.1/42.2 | 1.74 | 1.88 | 1.99 | 6.34E–8 | 9 | 31% | 92 | ||
| Protein disulfide isomerase | 506247.10 or 507611.370 | 180 | 4.42/4.6 | 20.9/53.5 | 1.46 | 3.7 | 3.6 | 2.44E–7 | 2 | 4% | 44 |
| Pyruvate dehydrogenase E1 beta subunit; putative | 510091.80 | 132 | 5.03/5.02 | 30.9/37.8 | 1.08 | −2.21 | −1.88 | 1.27E–6 | 5 | 20% | 191 |
| 133 | 4.62/5.02 | 40.7/37.8 | 1.02 | −4.58 | −3.83 | 4.13E–7 | 2 | 6% | 108 | ||
| Pyruvate kinase 2, putative | 507993.390 or 511281.60 | 68 | 5.97/7.44 | 46.6/54.6 | −1.3 | −4.94 | −4.8 | 1.73E–7 | 1 | 2% | 29 |
| Pyruvate phosphate dikinase | 510101.140 | 194 | 5.00/8.27 | 13.5/100.8 | 1.83 | 10.51 | 7.42 | 7.88E–9 | 2 | 3% | 94 |
| Receptor for activated C kinase 1, putative | 511211.120 or 511211.130 | 122 | 5.93/6.04 | 35.4/35.0 | −1.22 | −6.66 | −6.06 | 2.31E–9 | 3 | 11% | 122 |
| S-adenosylhomocysteine hydrolase | 511229.50 or 511589.200 | 193 | 5.25/6.64 | 12.9/48.4 | 1.41 | −1.23 | −1.1 | 3.74E–6 | 2 | 7% | 80 |
| Seryl-tRNA synthetase | 511163.1 or 506777.80 | 140 | 5.38/5.41 | 28.9/25.7 | 1.4 | −1.07 | 1.28 | 3.36E–6 | 3 | 19% | 97 |
| succinyl-CoA ligase [GDP-forming] beta-chain, putative | 507767.10 | 150 | 4.92/5.58 | 26.2/34.5 | 1.63 | 2.03 | 2.25 | 1.08E–6 | 2 | 7% | 87 |
| Thiol−dependent reductase 1; putative; thiol transferase; putative; glutathione s-transferase; putative | 509105.70 or 503419.30 | 62 | 6.00/5.83 | 51.9/50.7 | −1.18 | −2.07 | −1.56 | 4.56E–6 | 2 | 6% | 86 |
| 158 | 6.21/5.83 | 21.5/50.7 | −1.32 | −2.17 | −2.64 | 4.48E–6 | 1 | 3% | 32 | ||
| Trans-sialidase | 509927.10 | 186 | 4.18/6.67 | 21.0/54.7 | 1.67 | 4.7 | 4.71 | 6.10E–9 | 1 | 4% | 25 |
| Tryparedoxin peroxidase | 487507.10 or 509445.10 or 504839.28 or 507259.10 | 210 | 6.24/6.75 | 11.5/22/4 | 2.17 | 3.18 | 3.42 | 8.05E–5 | 1 | 5% | 33 |
| 211 | 6.66/6.75 | 17.0/22.4 | −1.52 | −3.96 | −1.82 | 3.25E–8 | 3 | 22% | 105 | ||
| 215 | 6.75/6.75 | 11.8/22.4 | 1.44 | −1.3 | 1.25 | 1.83E–6 | 3 | 19% | 109 | ||
| Tyrosine aminotransferase | 510187.20 and 510187.50 or 510187.40 or 510187.30 | 64 | 5.83/7.2 | 50.6/46.1 | −1.22 | −1.77 | −1.51 | 5.02E–5 | 1 | 2% | 58 |
| 79 | 6.25/6.14 | 44.9/46.1 | −2.36 | −31.03 | −28.73 | 1.34E–9 | 4 | 16% | 160 | ||
| 115 | 6.21/6.14 | 38.9/46.1 | −1.05 | −7.27 | −7.38 | 9.64E–9 | 4 | 11% | 110 | ||
| 116 | 6.18/6.14 | 37.0/46.1 | 1.09 | −5.43 | −4.73 | 8.44E–9 | 2 | 14% | 128 | ||
| Vacuolar ATP synthase subunit B | 506025.50 or 511209.10 | 37 | 5.71/5.29 | 59.1/55.5 | −1.69 | −3.54 | −4.01 | 2.44E–7 | 6 | 21% | 207 |
Figure 3Protein spots differentially expressed at all time points.
A) Number of downregulated and upregulated protein spots per time point. B) Venn diagram showing the overlaps of 32 protein spots differentially regulated among the three time points and of the 428 protein spots between 24 and 96 hours.
Figure 4Distribution of upregulated and downregulated protein spots versus molecular weight, pI, and fold change.
In the scatter plots, upregulated protein spots are shown in red and downregulated protein spots are shown in green. The correlation between molecular weight and pI or fold-change ratio is shown in (A) and (B), respectively. Spots with no significant difference in expression are colored gray. The blue line indicates the negative correlation between molecular weight and fold change.
Figure 5Boxplots of peptide molecular weights.
A) Distribution of the observed molecular weight in downregulated (green) or upregulated (red) protein spots at each time point analyzed. B) comparison between the distribution of the expected (E) and observed (O) molecular weights among downregulated or upregulated protein spots 24 and 96 hours after irradiation. A single asterisk corresponds to p<0.05 and a double asterisk corresponds to p<0.001.